World's Best Scientists 2026 revealed!
Carlo Federico Perno

Carlo Federico Perno

D-Index & Metrics

Immunology

D-Index
82
Citations
26270
World Ranking
1497
National Ranking
60

Medicine

D-Index
82
Citations
26301
World Ranking
16050
National Ranking
634

Carlo Federico Perno publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Carlo Federico Perno sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 728 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Carlo Federico Perno D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Carlo Federico Perno sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 82 D-Index — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Carlo Federico Perno is affiliated with the University of Milan in Italy. Their research focuses predominantly on the field of Medicine, with particular attention to Infectious Diseases, Epidemiology, and Virology. Their work also extends into related subfields such as Hepatology and Immunology.

The scientist has contributed extensively to studies on viral infections and treatment developments in the context of HIV/AIDS and SARS-CoV-2. Their research covers several main topics, including:

  • HIV/AIDS drug development and treatment
  • HIV Research and Treatment
  • SARS-CoV-2 and COVID-19 Research
  • HIV/AIDS Research and Interventions
  • COVID-19 Clinical Research Studies
  • Respiratory viral infections research
  • SARS-CoV-2 detection and testing

Their publication record includes work in a variety of scientific journals. The venues where they frequently publish encompass:

  • Journal of Antimicrobial Chemotherapy
  • Viruses
  • PLoS ONE
  • Scientific Reports
  • bioRxiv (Cold Spring Harbor Laboratory)

Frequent collaborators in their research include Francesca Ceccherini-Silberstein, Luna Colagrossi, Maria Mercedes Santoro, Vittorio Colizzi, and Joseph Fokam, with coauthoring counts ranging from over 50 to more than 80 joint works.

Selected recent papers by Carlo Federico Perno include:

  • "Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test," 2020, Journal of Clinical Microbiology
  • "Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis," 2021, AIDS
  • "Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients Semiquantitatively," 2020, Journal of Clinical Microbiology
  • "Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy," 2021, Nature Communications
  • "Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis," 2020, Journal of Infection

Best Publications

  • 1,2,3-Triazole-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D- ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"-oxathiole 2",2"-dioxide) (TSAO) analogues: synthesis and anti-HIV-1 activity.

    Rosa Alvarez;Sonsoles Velázquez;Ana San-Félix;Stefano Aquaro

  • PHASE I STUDIES OF 2',3'-DIDEOXYCYTIDINE IN SEVERE HUMAN IMMUNODEFICIENCY VIRUS INFECTION AS A SINGLE AGENT AND ALTERNATING WITH ZIDOVUDINE (AZT)

    Robert Yarchoan;Rose V. Thomas;Jean Pierre Allain;Nanette Mcatee

  • In vivo activity against HIV and favorable toxicity profile of 2',3'-dideoxyinosine

    Robert Yarchoan;Hiroaki Mitsuya;Rose V. Thomas;James M. Pluda

  • Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine.

    Robert Yarchoan;Robert Yarchoan;Pim Brouwers;Pim Brouwers;A. Robert Spitzer;A. Robert Spitzer;Jordan Grafman;Jordan Grafman;Jordan Grafman

  • Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido-2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine.

    C.-F. Perno;R. Yarchoan;D. A. Cooney;N. R. Hartman

  • Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative.

    M. Baba;H. Tanaka;E. De Clercq;R. Pauwels

  • Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.

    C F Perno;R Yarchoan;D A Cooney;N R Hartman

  • European guidelines on the clinical management of HIV-1 tropism testing

    L.P.R. Vandekerckhove;Annemarie Wensing;Rolf Kaiser;F. Brun-Vézinet

  • Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

    John Gregson;Michele Tang;Nicaise Ndembi;Raph L Hamers

  • Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir.

    Stefano Aquaro;Raffaele Caliò;Jan Balzarini;Maria Concetta Bellocchi

  • 2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2'-dioxide)pyrimidine (TSAO) nucleoside analogues: highlyselective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcriptase.

    Jan Balzarini;María Jesús Pérez-Pérez;Ana San-Félix;Dominique Schols

  • Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro.

    Z Hao;D A Cooney;N R Hartman;C F Perno

  • Therapeutic drug monitoring in HIV infection: current status and future directions.

    David J. Back;Giorgio Gatti;Courtney Fletcher;Rodolphe Garaffo

  • HIV-1 Genetic Variability and Clinical Implications.

    Maria Mercedes Santoro;Carlo Federico Perno

  • Cytomegalovirus Coinfection Is Associated With an Increased Risk of Severe Non–AIDS-Defining Events in a Large Cohort of HIV-Infected Patients

    Miriam Lichtner;Paola Cicconi;Serena Vita;Alessandro Cozzi-Lepri

  • Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants

    Vincenzo Mollace;Hans S.L.M. Nottet;Pascal Clayette;Maria C. Turco

  • Mannose-Specific Plant Lectins from the Amaryllidaceae Family Qualify as Efficient Microbicides for Prevention of Human Immunodeficiency Virus Infection

    Jan Balzarini;Sigrid Hatse;Kurt Vermeire;Katrien Princen

  • Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018.

    Maria C. Sorbo;Valeria Cento;Velia C. Di Maio;Anita Y.M. Howe

  • Relative Potency of Protease Inhibitors in Monocytes/Macrophages Acutely and Chronically Infected with Human Immunodeficiency Virus

    Carlo Federico Perno;Fonda M. Newcomb;David A. Davis;Stefano Aquaro

  • A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients.

    Kristel Van Laethem;Andrea De Luca;Andrea Antinori;Antonello Cingolani

Frequent Co-Authors

Francesca Ceccherini-Silberstein
Francesca Ceccherini-Silberstein University of Rome Tor Vergata
Andrea Antinori
Andrea Antinori Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani
Massimo Andreoni
Massimo Andreoni University of Rome Tor Vergata
Massimo Ciccozzi
Massimo Ciccozzi Università Campus Bio-Medico
Antonella d'Arminio Monforte
Antonella d'Arminio Monforte University of Milan
Cristina Mussini
Cristina Mussini University of Modena and Reggio Emilia
Jan Balzarini
Jan Balzarini KU Leuven
Claudio Maria Mastroianni
Claudio Maria Mastroianni Sapienza University of Rome
Adriana Ammassari
Adriana Ammassari Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani
Adriano Lazzarin
Adriano Lazzarin Vita-Salute San Raffaele University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in combining immunology with healthcare, pursuing nursing degrees can open diverse career opportunities. Many students prefer programs that balance quality with accessibility, making the easy admission LPN programs an appealing starting point. These programs offer streamlined entry processes and foundational clinical skills relevant to immunological patient care.

Advancing your qualifications through nurse practitioner degrees is another pathway. The easiest FNP program options ensure you can specialize without excessive barriers, helping you gain expertise in family health with immunology applications. For mental health-focused professionals, the top PMHNP programs provide excellent clinical placement support, critical for hands-on experience in psychiatric and immunological disorders.

Cost is often a major consideration. Many learners seek affordable routes such as the cheap psych NP programs, which combine quality training with financial practicality. These programs support career advancement in psychiatric nursing fields closely linked to immunology research and treatment.

Exploring these related online degrees allows you to tailor your immunology career path according to your interests, budget, and desired specialization.

Best Scientists Citing Carlo Federico Perno

Trending Scientists